Best practice in reporting corona studies: Minimum information about Nanomaterial Biocorona Experiments (MINBE).
暂无分享,去创建一个
[1] A. Doucet-Panaye,et al. Investigation of the influence of protein corona composition on gold nanoparticle bioactivity using machine learning approaches , 2016, SAR and QSAR in environmental research.
[2] Nigel W. Hardy,et al. Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project , 2008, Nature Biotechnology.
[3] Edmund J. Crampin,et al. Minimum information reporting in bio–nano experimental literature , 2018, Nature Nanotechnology.
[4] Maryam Mobed-Miremadi,et al. Machine learning provides predictive analysis into silver nanoparticle protein corona formation from physicochemical properties. , 2018, Environmental science. Nano.
[5] Thomas N. Lawson,et al. Metabolomic method to detect a metabolite corona on amino-functionalized polystyrene nanoparticles , 2019, Nanotoxicology.
[6] Andrew Emili,et al. Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. , 2014, ACS nano.
[7] Rigoberto Hernandez,et al. Biological Responses to Engineered Nanomaterials: Needs for the Next Decade , 2015, ACS central science.
[8] Lennart Martens,et al. The minimum information about a proteomics experiment (MIAPE) , 2007, Nature Biotechnology.
[9] Birgit Schilling,et al. Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometry. , 2010, Journal of proteome research.
[10] Stefan Tenzer,et al. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. , 2011, ACS nano.
[11] M. Mortimer,et al. NanoEHS beyond Toxicity - Focusing on Biocorona. , 2017, Environmental science. Nano.
[12] Lennart Martens,et al. Quality control in mass spectrometry-based proteomics. , 2018, Mass spectrometry reviews.
[13] Ju Yong Lee,et al. Analysis of lipid adsorption on nanoparticles by nanoflow liquid chromatography-tandem mass spectrometry , 2018, Analytical and Bioanalytical Chemistry.
[14] Kenneth A. Dawson,et al. Protein–Nanoparticle Interactions , 2008, Nano-Enabled Medical Applications.
[15] N. Verma,et al. Identification and characterization of small organic compounds within the corona formed around engineered nanoparticles , 2018 .
[16] Andrew J Chetwynd,et al. Corona Isolation Method Matters: Capillary Electrophoresis Mass Spectrometry Based Comparison of Protein Corona Compositions Following On-Particle versus In-Solution or In-Gel Digestion , 2019, Nanomaterials.
[17] Mei-Ling Cheng,et al. Fatty acids and small organic compounds bind to mineralo-organic nanoparticles derived from human body fluids as revealed by metabolomic analysis. , 2016, Nanoscale.
[18] Martin Eisenacher,et al. Guidelines for reporting quantitative mass spectrometry based experiments in proteomics. , 2013, Journal of proteomics.
[19] K. Landfester,et al. Beyond the protein corona - lipids matter for biological response of nanocarriers. , 2018, Acta biomaterialia.
[20] Morteza Mahmoudi,et al. Debugging Nano-Bio Interfaces: Systematic Strategies to Accelerate Clinical Translation of Nanotechnologies. , 2018, Trends in biotechnology.
[21] Philip B. Stark,et al. Before reproducibility must come preproducibility , 2018, Nature.
[22] Stefan Tenzer,et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. , 2013, Nature nanotechnology.
[23] Stefan Tenzer,et al. Quantitative profiling of the protein coronas that form around nanoparticles , 2014, Nature Protocols.
[24] S. Stolte,et al. Changing environments and biomolecule coronas: consequences and challenges for the design of environmentally acceptable engineered nanoparticles , 2018 .
[25] Warren C W Chan,et al. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. , 2012, Chemical Society reviews.
[26] Wolfgang J Parak,et al. A Decade of the Protein Corona. , 2017, ACS nano.
[27] Chris F. Taylor,et al. Guidelines for reporting the use of mass spectrometry informatics in proteomics , 2008, Nature Biotechnology.
[28] Jim X. Shen,et al. A novel and cost effective method of removing excess albumin from plasma/serum samples and its impacts on LC-MS/MS bioanalysis of therapeutic proteins. , 2014, Analytical chemistry.
[29] Chris F. Taylor,et al. Guidelines for reporting the use of mass spectrometry in proteomics , 2008, Nature Biotechnology.
[30] Ronald J. Moore,et al. Quantitative proteomics analysis of adsorbed plasma proteins classifies nanoparticles with different surface properties and size , 2011, Proteomics.